MicroRNA as Biomarker for Breast Cancer Detection | ||||
| Benha Journal of Applied Sciences | ||||
| Article 39, Volume 6, Issue 5, September 2021, Page 243-245 PDF (543.34 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2021.205388 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| N.F. Al-Hussein1; N.M. Emarah2; Y.M. Marei1; H.E. Nasr1; R.S. Mohamed1 | ||||
| 1Medical Biochemistry & Molecular Biology, Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
| 2Pathology, Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
| Abstract | ||||
| Women are more likely than men to die from cancer if they have breast cancer (BC). It was triggered by a slew of risk factors. Breast cancer patients have a better prognosis if they are diagnosed early. Recent research has shown that microRNAs may play an important role in the early detection and prognosis of breast cancer. There are approximately 23 nucleotides in microRNAs, making them tiny uncoding RNAs. Breast cancer development may be slowed or halted through the control of cell proliferation and death by miRNAs. MicroRNA-329 (miRNA-329) expression was examined in BC females to see whether it was associated with the disease's stage and to determine if miRNA-329 might be used in the diagnosis of BC. | ||||
| Keywords | ||||
| Breast Cancer; MiRNAs | ||||
|
Statistics Article View: 99 PDF Download: 229 |
||||
